1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
Western European Cardiac Troponin Diagnostics Market, Forecast to 2021

Western European Cardiac Troponin Diagnostics Market, Forecast to 2021

  • May 2018
  • 81 pages
  • ID: 5436747
  • Format: PDF
  • By Frost & Sullivan


Table of Contents

Emerging Biomarkers Disrupt and Spur Growth in the Heart Disease Segment
Cardiac troponins have now become the gold standard for early diagnosis of acute myocardial infarction, making them indispensable for clinical diagnosis of Acute Coronary Syndrome (ACS).Cardiac troponins play a key role in minimizing hospital stays and reducing admission rate which are the biggest contributors to overall healthcare expenditure.

For example, in Europe and the US, the total cost of heart failure associated health expenditure is valued at $ 100 billion, of which 70% is due to hospitalization. ECG can detect only one-thirds of patients with persistent ST-segment elevation (STEMI), whereas cardiac troponins can distinguish patients without ST-segment elevation (NSTEACS or non-ST segment elevation ACS) who require a conservative unstable angina (UA) or early-invasive approach (NSTEMI).The advent of new biomarkers (e.g., H-FABP) over high-sensitivity troponins, or in combination, is currently explored for clinical utility and cost-effectiveness.

Cardiovascular diseases (CVD) remain the leading cause of mortality and a major cause of morbidity in Europe.The WEU cardiac diagnostic market is a high-value market, with a consistent increase in demand due to regulatory changes that are set to impact the cardiac diagnostics market across Europe.

The objective of this research is to establish an understanding in the segment of cardiac biomarker troponin used for the diagnosis of acute myocardial Infarction. The research covers the revenue generated by the use of cardiac troponin tests for diagnosis of acute myocardial infarction.

Physicians are demanding a more accurate test which could reduce the burden in the healthcare settings. For patients under acute critical conditions (e.g., myocardial infarction), fast results and quick diagnosis are required. Rising prevalence of MI and increasing morbidity in the region will fuel the growth of diagnostic testings. Moreover, demands from physicians for more accurate and sensitive results will push researchers and investments for the diagnosis of MI.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Islet Amyloid Polypeptide - Pipeline Review, H1 2020

Islet Amyloid Polypeptide - Pipeline Review, H1 2020

  • $ 3500
  • January 2020

Islet Amyloid Polypeptide - Pipeline Review, H1 2020SummaryIslet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) pipeline Target constitutes close to 12 ...

Chronic Obstructive Pulmonary Disease: Epidemiology Forecast to 2028

Chronic Obstructive Pulmonary Disease: Epidemiology Forecast to 2028

  • $ 3995
  • December 2019

Chronic Obstructive Pulmonary Disease: Epidemiology Forecast to 2028SummaryChronic Obstructive Pulmonary Disease (COPD) is a progressive disease characterized by coughing that produces large amounts of ...

Birch Pollen Allergy - Pipeline Review, H1 2020

Birch Pollen Allergy - Pipeline Review, H1 2020

  • $ 2000
  • January 2020

Birch Pollen Allergy - Pipeline Review, H1 2020SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Birch Pollen Allergy - Pipeline Review, H1 2020, provides an overview of the Birch ...


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on